RICHMAN ERIC I
Insider CIK 1313876 · NBSE Director · PIP See Remarks, Director · NONE Director · GANX Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GANX Gain Therapeutics, Inc. | A Award deriv | 2025-06-24 | 2025-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GANX Gain Therapeutics, Inc. | P Buy | 2024-07-01 | 2024-07-01 | 12,000 | $1.21 | $14.5K | 289,629 | SEC↗ |
| GANX Gain Therapeutics, Inc. | P Buy | 2024-07-01 | 2024-07-01 | 5,000 | $1.23 | $6.2K | 277,629 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2024-06-24 | 2024-06-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GANX Gain Therapeutics, Inc. | M Exercise deriv | 2023-09-20 | 2023-09-22 | 54,900 | — | $0 | 0 | SEC↗ |
| GANX Gain Therapeutics, Inc. | M Exercise | 2023-09-20 | 2023-09-22 | 54,900 | — | $0 | 272,629 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2022-09-20 | 2022-09-22 | 329,400 | — | $0 | 329,400 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2022-09-20 | 2022-09-22 | 54,900 | — | $0 | 54,900 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | A Award deriv | 2022-09-09 | 2022-09-12 | 37,600 | — | $0 | 37,600 | SEC↗ |
| GANX Gain Therapeutics, Inc. | P Buy | 2022-05-25 | 2022-05-27 | 2,482 | $2.58 | $6.4K | 217,729 | SEC↗ |
| GANX Gain Therapeutics, Inc. | P Buy | 2022-05-20 | 2022-05-23 | 9,256 | $2.83 | $26.2K | 215,247 | SEC↗ |
| GANX Gain Therapeutics, Inc. | P Buy | 2022-05-19 | 2022-05-23 | 4,000 | $2.71 | $10.8K | 205,991 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | P Buy | 2022-03-04 | 2022-03-07 | 1,000 | $1.62 | $1.6K | 44,960 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | P Buy | 2022-03-03 | 2022-03-07 | 1,300 | $1.72 | $2.2K | 43,960 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | P Buy | 2022-03-01 | 2022-03-07 | 1,580 | $1.58 | $2.5K | 42,660 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | A Award deriv | 2021-08-19 | 2021-09-17 | 38,135 | — | $0 | 38,135 | SEC↗ |
| GANX Gain Therapeutics, Inc. | P Buy | 2021-08-16 | 2022-04-21 | 4,922 | $7.87 | $38.7K | 216,820 | SEC↗ |
| GANX Gain Therapeutics, Inc. | M Exercise | 2021-08-16 | 2021-08-17 | 4,922 | $7.87 | $38.7K | 216,820 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | P Buy | 2021-04-26 | 2021-04-27 | 5,000 | $5.00 | $25.0K | 41,080 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | A Award deriv | 2020-09-09 | 2020-09-11 | 14,634 | — | $0 | 14,634 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | P Buy | 2020-04-30 | 2020-05-04 | 2,500 | $6.00 | $15.0K | 27,747 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | P Buy | 2020-04-30 | 2020-05-04 | 8,333 | $6.00 | $50.0K | 36,080 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award deriv | 2020-02-28 | 2020-03-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award | 2020-02-28 | 2020-03-03 | 7,500 | — | $0 | 44,030 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | A Award deriv | 2019-07-12 | 2019-07-16 | 227,330 | — | $0 | 227,330 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | A Award | 2019-07-12 | 2019-07-16 | 25,247 | — | $0 | 25,247 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award deriv | 2019-03-13 | 2019-03-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award deriv | 2018-06-22 | 2018-06-25 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | P Buy | 2018-06-08 | 2018-06-11 | 5,230 | $4.78 | $25.0K | 36,530 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | P Buy | 2017-11-09 | 2017-11-13 | 25,000 | $2.15 | $53.8K | 31,300 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | M Exercise deriv | 2017-07-13 | 2017-07-17 | 2,800 | — | $0 | 0 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | M Exercise | 2017-07-13 | 2017-07-17 | 2,800 | $2.68 | $7.5K | 6,300 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award deriv | 2017-06-06 | 2017-06-08 | 78,144 | — | $0 | 78,144 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award deriv | 2017-02-14 | 2017-02-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise deriv | 2016-11-22 | 2016-11-23 | 240,000 | — | $0 | 0 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise deriv | 2016-11-22 | 2016-11-23 | 20,000 | — | $0 | 0 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise deriv | 2016-11-22 | 2016-11-23 | 135,660 | — | $0 | 0 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise deriv | 2016-11-22 | 2016-11-23 | 20,000 | — | $0 | 0 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise deriv | 2016-11-22 | 2016-11-23 | 37,500 | — | $0 | 0 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise deriv | 2016-11-22 | 2016-11-23 | 30,573 | — | $0 | 0 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise | 2016-11-22 | 2016-11-23 | 240,000 | $1.94 | $465.6K | 722,395 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise | 2016-11-22 | 2016-11-23 | 20,000 | $1.69 | $33.8K | 878,055 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise | 2016-11-22 | 2016-11-23 | 135,660 | $1.71 | $232.0K | 858,055 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise | 2016-11-22 | 2016-11-23 | 20,000 | $2.20 | $44.0K | 898,055 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise | 2016-11-22 | 2016-11-23 | 37,500 | $1.19 | $44.6K | 482,395 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise | 2016-11-22 | 2016-11-23 | 30,573 | $2.46 | $75.2K | 444,895 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise deriv | 2016-09-28 | 2016-09-30 | 37,500 | — | $0 | 37,500 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise deriv | 2016-09-28 | 2016-09-30 | 100,000 | — | $0 | 0 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise deriv | 2016-09-28 | 2016-09-30 | 100,000 | — | $0 | 0 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise | 2016-09-28 | 2016-09-30 | 100,000 | $1.48 | $148.0K | 376,822 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise | 2016-09-28 | 2016-09-30 | 37,500 | $1.19 | $44.6K | 414,322 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise | 2016-09-28 | 2016-09-30 | 100,000 | $1.51 | $151.0K | 276,822 | SEC↗ |
| PIP PHARMATHENE, INC | A Award deriv | 2016-06-01 | 2016-06-03 | 20,000 | $2.20 | $44.0K | 20,000 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise deriv | 2016-04-13 | 2016-04-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise deriv | 2016-04-13 | 2016-04-15 | 91,121 | — | $0 | 0 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise deriv | 2016-04-13 | 2016-04-15 | 150,000 | — | $0 | 0 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise deriv | 2016-04-13 | 2016-04-15 | 13,233 | — | $0 | 0 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise | 2016-04-13 | 2016-04-15 | 13,233 | $1.76 | $23.3K | 190,055 | SEC↗ |
| PIP PHARMATHENE, INC | S Sale | 2016-04-13 | 2016-04-15 | 13,233 | $2.20 | $29.1K | 176,822 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise | 2016-04-13 | 2016-04-15 | 150,000 | $1.16 | $174.0K | 326,822 | SEC↗ |
| PIP PHARMATHENE, INC | S Sale | 2016-04-13 | 2016-04-15 | 150,000 | $2.20 | $330.0K | 176,822 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise | 2016-04-13 | 2016-04-15 | 91,121 | $1.16 | $105.7K | 267,943 | SEC↗ |
| PIP PHARMATHENE, INC | S Sale | 2016-04-13 | 2016-04-15 | 91,121 | $2.20 | $200.5K | 176,822 | SEC↗ |
| PIP PHARMATHENE, INC | S Sale | 2016-04-13 | 2016-04-15 | 75,000 | $2.20 | $165.0K | 176,822 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise | 2016-04-13 | 2016-04-15 | 75,000 | $1.19 | $89.3K | 251,822 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise deriv | 2016-04-08 | 2016-04-11 | 6,400 | — | $0 | 13,233 | SEC↗ |
| PIP PHARMATHENE, INC | S Sale | 2016-04-08 | 2016-04-11 | 6,400 | $2.20 | $14.1K | 176,822 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise | 2016-04-08 | 2016-04-11 | 6,400 | $1.76 | $11.3K | 183,222 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise deriv | 2016-04-07 | 2016-04-11 | 5,367 | — | $0 | 19,633 | SEC↗ |
| PIP PHARMATHENE, INC | S Sale | 2016-04-07 | 2016-04-11 | 5,367 | $2.20 | $11.8K | 176,822 | SEC↗ |
| PIP PHARMATHENE, INC | M Exercise | 2016-04-07 | 2016-04-11 | 5,367 | $1.76 | $9.4K | 182,189 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award deriv | 2016-01-28 | 2016-02-01 | 9,000 | — | $0 | 9,000 | SEC↗ |
| PIP PHARMATHENE, INC | A Award deriv | 2015-08-02 | 2015-08-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | P Buy | 2015-03-13 | 2015-03-17 | 1,000 | $7.82 | $7.8K | 3,500 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | P Buy | 2015-03-13 | 2015-03-17 | 2,500 | $7.90 | $19.8K | 2,500 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award deriv | 2015-01-30 | 2015-02-03 | 9,000 | — | $0 | 9,000 | SEC↗ |
| PIP PHARMATHENE, INC | A Award deriv | 2014-12-11 | 2014-12-15 | 271,320 | — | $0 | 271,320 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award deriv | 2014-06-19 | 2014-06-23 | 9,000 | — | $0 | 9,000 | SEC↗ |
| PIP PHARMATHENE, INC | A Award deriv | 2014-01-29 | 2014-01-31 | 320,000 | — | $0 | 320,000 | SEC↗ |
| PIP PHARMATHENE, INC | A Award deriv | 2012-12-12 | 2012-12-14 | 150,000 | — | $0 | 150,000 | SEC↗ |
| NONE ADMA BIOLOGICS, INC. | A Award deriv | 2012-04-04 | 2012-04-06 | 26,517 | — | $0 | 26,517 | SEC↗ |
| PIP PHARMATHENE, INC | F Tax w/h | 2012-03-07 | 2012-03-08 | 22,500 | — | $0 | 176,822 | SEC↗ |
| NONE R&R ACQUISITION VI, INC | A Award deriv | 2012-02-13 | 2012-02-15 | 2,205 | — | $0 | 2,205 | SEC↗ |
| NONE R&R ACQUISITION VI, INC | A Award deriv | 2012-02-13 | 2012-02-15 | 3,677 | — | $0 | 3,677 | SEC↗ |